TFEB can upregulate the expression of nearly two-thirds of autophagy–lysosome genes and its overexpression shows potential therapeutic effects in cardiovascular disease by rescuing lipid-induced lysosomal dysfunction [16, 52, 54] as well as enhancing lipolysis [55]. This evidence concerns the gene TFEB and cardiovascular disorder.